Real-world clinical outcomes of cabozantinib (cabo) as a second-line (2L) treatment for advanced hepatocellular carcinoma (aHCC)

被引：0
|
作者：
Ahn, D. [1 ]
Park, N. J. [2 ]
Locker, M. C. [2 ]
Zhou, Z-Y. [3 ]
Nie, X. [3 ]
Wang, T. [3 ]
Yu, S. [2 ]
机构：
[1] Mayo Clin, Dept Med Oncol, Phoenix, AZ USA
[2] Exelixis Inc, Dept Med Affairs, Alameda, CA USA
[3] Anal Grp Inc, Dept Healthcare, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1000P
引用
收藏
页码：S613 / S613
页数：1
相关论文
共 50 条
  • [41] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Hiroaki Kanzaki
    Sadahisa Ogasawara
    Tomomi Okubo
    Norio Itokawa
    Ryohei Yoshino
    Kentaro Fujimoto
    Tadayoshi Kogure
    Sae Yumita
    Takamasa Ishino
    Keita Ogawa
    Terunao Iwanaga
    Miyuki Nakagawa
    Kisako Fujiwara
    Ryuta Kojima
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Naoya Kanogawa
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Ei Itobayashi
    Masanori Atsukawa
    Jun Kato
    Naoya Kato
    Drugs - Real World Outcomes, 2023, 10 : 513 - 520
  • [42] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Kanzaki, Hiroaki
    Ogasawara, Sadahisa
    Okubo, Tomomi
    Itokawa, Norio
    Yoshino, Ryohei
    Fujimoto, Kentaro
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Iwanaga, Terunao
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Kojima, Ryuta
    Koroki, Keisuke
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Itobayashi, Ei
    Atsukawa, Masanori
    Kato, Jun
    Kato, Naoya
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (04) : 513 - 520
  • [43] Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
    Kelley, Robin Kate
    Ryoo, Baek-Yeol
    Merle, Philippe
    Park, Joong-Won
    Bolondi, Luigi
    Chan, Stephen L.
    Lim, Ho Yeong
    Baron, Ari D.
    Parnis, Francis
    Knox, Jennifer
    Cattan, Stephane
    Yau, Thomas
    Lougheed, Julie C.
    Milwee, Steven
    El-Khoueiry, Anthony B.
    Cheng, Ann-Lii
    Meyer, Tim
    Abou-Alfa, Ghassan K.
    ESMO OPEN, 2020, 5 (04) : 1 - 9
  • [44] REAL-WORLD TREATMENT PATTERNS AND COSTS AMONG ADVANCED HEPATOCELLULAR CARCINOMA (AHCC) PATIENTS TREATED WITH SYSTEMIC CANCER THERAPIES
    Bonafede, M. M.
    Cai, C.
    Singh, P.
    Parikh, N.
    Cappell, K. A.
    Jariwala-Parikh, K.
    Korytowsky, B.
    VALUE IN HEALTH, 2017, 20 (05) : A131 - A131
  • [45] A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).
    Cheung, Winson Y.
    Zhang, Hanbo
    Tang, Patricia A.
    Spratlin, Jennifer L.
    Lee-Ying, Richard M.
    Goodwin, Rachel Anne
    Meyers, Brandon Matthew
    Armstrong, Dawn Elizabeth
    Ramjeesingh, Ravi
    Vickers, Michael M.
    Kim, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [46] Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma
    Rimassa, Lorenza
    Woerns, Marcus-Alexander
    LIVER INTERNATIONAL, 2020, 40 (08) : 1800 - 1811
  • [47] Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan
    Tsai, Y-C.
    Li, J-R.
    Su, P. J.
    Su, Y-L.
    Chung, H-J.
    Li, C-C.
    Huang, C-P.
    Guo, J-C.
    Chen, C-S.
    Wang, E.
    Perrot, V.
    Chang, Y. H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1487 - S1488
  • [48] Real-world outcomes with second-line therapy in advanced esophageal squamous cell carcinoma using SEER-Medicare data
    Danese, Mark
    Gricar, Joseph
    Abraham, Pranav
    FUTURE ONCOLOGY, 2022, 18 (08) : 927 - 936
  • [49] Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England
    Moore, Sally
    Cornic, Laura
    Crossman-Barnes, Christina-Jane
    Jose, Sophie
    Khalaf, Zeyad
    Yong, Kwee
    Soutar, Megan
    Woods, Philip
    EJHAEM, 2025, 6 (01):
  • [50] Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma
    O'Sullivan, Dylan E.
    Boyne, Devon J.
    Syed, Iqra A.
    Shephard, Cal
    Clouthier, Derek L.
    Yoshida, Eric M.
    Spratlin, Jennifer L.
    Batra, Atul
    Rigo, Rodrigo
    Hannouf, Malek
    Hu, Xun Yang
    Jarada, Tamer
    Brenner, Darren R.
    Cheung, Winson Y.
    CANADIAN LIVER JOURNAL, 2022, 5 (04): : 476 - 492
12345